Epitope mapping of prostate-specific antigen with monoclonal antibodies. 1996

D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.

Prostate-specific antigen (PSA) is a widely used marker for screening and monitoring prostate cancer. We identified and characterized the epitopes of two anti-PSA monoclonal antibodies (mAbs) designated B80 and B87. The epitopes were initially mapped as nonoverlapping by developing a sandwich immunoassay to measure PSA with the two anti-PSA mAbs. The two antibodies do not cross-react with homologous pancreatic kallikrein, but recognize epitopes unique to PSA. B80 and B87 can recognize both free and complexed PSA and hence measure total PSA. Epitope scanning and bacteriophage peptide library affinity selection procedures were used to identify and locate an epitope on PSA. A possible epitope for B80 was identified as being located on or near PSA amino acid residues 50-58 (-GRH-SLFHP-). The epitope for B87 was likely on an exposed nonlinear conformational determinant, unique to PSA, and not masked by the binding of B80 or alpha 1-antichymotrypsin.

UI MeSH Term Description Entries
D008297 Male Males
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002918 Chymotrypsin A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side. Alpha-Chymotrypsin Choay,Alphacutanée,Avazyme
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
January 1999, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
December 2002, Clinical chemistry,
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
January 2002, Immunology letters,
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
November 1988, Current eye research,
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
January 1999, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
January 1999, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
March 1999, Immunology letters,
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
June 2004, Current opinion in investigational drugs (London, England : 2000),
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
January 1989, The Journal of urology,
D C Jette, and F T Kreutz, and B A Malcolm, and D S Wishart, and A A Noujaim, and M R Suresh
January 1999, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Copied contents to your clipboard!